Commentary

Por Jacobs, Johannes W G, Geenen, R
Publicado em 2001

The psychological impact of the COVID-19 pandemic on Dutch people with and without an inflammatory rheumatic disease

Por Koppert, Tim Y, Jacobs, Johannes W G, Geenen, Rinie
Publicado no Rheumatology (Oxford) (2020)

Eosinophilic fasciitis

Por Tsoi, Ka Lai, Custers, Martijn, Bij de Vaate, Liesbeth, Jacobs, Johannes W G
Publicado no BMJ Case Rep (2012)

Tocilizumab as monotherapy or combination therapy for treating active rheumatoid arthritis: a meta-analysis of efficacy and safety reported in randomized controlled trials

Por Teitsma, Xavier M., Marijnissen, Anne Karien A., Bijlsma, Johannes W. J., Lafeber, Floris P. J., Jacobs, Johannes W. G.
Publicado no Arthritis Res Ther (2016)

Do we need bone mineral density to estimate osteoporotic fracture risk? A 10-year prospective multicentre validation study

Por Marques, Andréa, Lucas, Raquel, Simões, Eugénia, Verstappen, Suzanne M M, Jacobs, Johannes W G, da Silva, Jose A P
Publicado no RMD Open (2017)

Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis

Por Rubbert-Roth, Andrea, Aletaha, Daniel, Devenport, Jenny, Sidiropoulos, Paris N, Luder, Yves, Edwardes, Michael D, Jacobs, Johannes W G
Publicado no Rheumatology (Oxford) (2020)

Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

Por Lamers-Karnebeek, Femke B G, Luime, Jolanda J, Jansen, Tim L, van Riel, Piet L C M, Jacobs, Johannes W G
Publicado no Rheumatology (Oxford) (2020)

Comprehensive exploratory autoantibody profiling in patients with early rheumatoid arthritis treated with methotrexate or tocilizumab

Por Teitsma, Xavier M., Devenport, Jenny, Jacobs, Johannes W. G., Pethö-Schramm, Attila, Borm, Michelle E. A., Budde, Petra, Bijlsma, Johannes W. J., Lafeber, Floris P. J. G.
Publicado no PLoS One (2020)

Identification of differential co-expressed gene networks in early rheumatoid arthritis achieving sustained drug-free remission after treatment with a tocilizumab-based or methotre...

Por Teitsma, Xavier M., Jacobs, Johannes W. G., Mokry, Michal, Borm, Michelle E. A., Pethö-Schramm, Attila, van Laar, Jacob M., Bijlsma, Johannes W. J., Lafeber, Floris P. J.
Publicado no Arthritis Res Ther (2017)

Determining the Lowest Optimally Effective Methotrexate Dose for Individual RA Patients Using Their Dose Response Relation in a Tight Control Treatment Approach

Por Nair, Sandhya C., Jacobs, Johannes W. G., Bakker, Marije F., Jahangier, Z. Nazira, Bijlsma, Johannes W. J., van Laar, Jacobs M., Lafeber, Floris P. J. G., Welsing, Paco M. J.
Publicado no PLoS One (2016)

Baseline metabolic profiles of early rheumatoid arthritis patients achieving sustained drug-free remission after initiating treat-to-target tocilizumab, methotrexate, or the combin...

Por Teitsma, Xavier M, Yang, Wei, Jacobs, Johannes W G, Pethö-Schramm, Attila, Borm, Michelle E A, Harms, Amy C, Hankemeier, Thomas, van Laar, Jacob M, Bijlsma, Johannes W J, Lafeber, Floris P J G
Publicado no Arthritis Res Ther (2018)

Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protoc...

Por van der Leeuw, Matthijs S., Welsing, Paco M. J., de Hair, Maria J. H., Jacobs, Johannes W. G., Marijnissen, Anne C. A., Linn-Rasker, Suzanne P., Fodili, Faouzia, Bos, Reinhard, Tekstra, Janneke, van Laar, Jacob M.
Publicado no Trials (2020)

Utility of the HandScan in monitoring disease activity and prediction of clinical response in rheumatoid arthritis patients: an explorative study

Por Verhoeven, Maxime M A, Tekstra, Janneke, Marijnissen, Anne C A, Meier, Anna J L, Westgeest, Antonius A A, Lafeber, Floris P J G, Jacobs, Johannes W G, van Laar, Jacob M, Welsing, Paco M J
Publicado no Rheumatol Adv Pract (2021)

Effectiveness and safety over 3 years after the 2-year U-Act-Early trial of the strategies initiating tocilizumab and/or methotrexate

Por Verhoeven, Maxime M A, Tekstra, Janneke, Welsing, Paco M J, Pethö-Schramm, Attila, Borm, Michelle E A, Bruyn, George A W, Bos, Reinhard, Griep, Ed N, Klaasen, Ruth, van Laar, Jacob M, Lafeber, Floris P J G, Bijlsma, Johannes W J, de Hair, Marjolein J H, Jacobs, Johannes W G
Publicado no Rheumatology (Oxford) (2020)

Determinants of Discordance in Patients’ and Physicians’ Rating of Rheumatoid Arthritis Disease Activity

Por KHAN, NASIM A., SPENCER, HORACE J., ABDA, ESAM, AGGARWAL, AMITA, ALTEN, RIEKE, ANCUTA, CODRINA, ANDERSONE, DAINA, BERGMAN, MARTIN, CRAIG-MULLER, JURGEN, DETERT, JACQUELINE, GEORGESCU, LIA, GOSSEC, LAURE, HAMOUD, HISHAM, JACOBS, JOHANNES W. G., LAURINDO, IEDA MARIA MAGALHAES, MAJDAN, MARIA, NARANJO, ANTONIO, PANDYA, SAPAN, POHL, CHRISTOF, SCHETT, GEORG, SELIM, ZAHRAA I., TOLOZA, SERGIO, YAMANAKA, HISAHI, SOKKA, TUULIKKI
Publicado em 2012